Crinetics Pharmaceuticals Inc share price logo

Crinetics Pharmaceuticals Inc Share Price

NASDAQ: CRNX

Mid Cap

$33.80

-0.20

(-0.59%)

as on

Crinetics Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $33.42
    $34.27
    downward going graph

    1.12%

    Downside

    1.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $24.1
    $62.53
    downward going graph

    28.70%

    Downside

    85.00%

    Upside

    downward going graph

Crinetics Pharmaceuticals Inc share price movements today

Previous Close
$34.00
Open
$33.99
Volume
864.5K
Day's Low - High
$33.42 - $34.27
52 Week Low - High
$24.1 - $62.53

Crinetics Pharmaceuticals Inc Historical Returns

1 Month Return
+ 13.93 %
3 Month Return
+ 10.17 %
1 Year Return
-34.94 %
3 Year Return
+ 63.78 %
5 Year Return
+ 118.48 %

Crinetics Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Crinetics Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2B

EPS (TTM)

-4.6655

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.31

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-419.6M

Revenue (TTM)

1.4M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Crinetics Pharmaceuticals Inc Stock Valuation

Track how Crinetics Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Crinetics Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-16.31x)

September 15, 2025

Industry (10.13x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -16.31x

Crinetics Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Crinetics Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.2B118.48%-16.310.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Crinetics Pharmaceuticals Inc Stock including INR - Dollar returns

The Crinetics Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Crinetics Pharmaceuticals Inc investment value today

Current value as on today

₹67,811

Returns

₹32,189

(-32.19%)

Returns from Crinetics Pharmaceuticals Inc Stock

₹37,175 (-37.17%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Crinetics Pharmaceuticals Inc Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Crinetics Pharmaceuticals Inc. Average target price of $70

Crinetics Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Crinetics Pharmaceuticals Inc.

What analysts predicted

51.71%UPSIDE

Target Price

$70

Current Price

$33.8

Analyzed by

20 Analysts

Target

$70.00

Crinetics Pharmaceuticals Inc target price $70, a slight upside of 51.71% compared to current price of $33.8. According to 20 analysts rating.

Crinetics Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Crinetics Pharmaceuticals Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Crinetics Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
2
0
0
-
0
0
-
-
0
1
Gross Profit
2
0
0
0
0
-57
0
0
0
0
Operating Income
-47
-52
-58
-62
-73
-82
-87
-94
-111
-129
EBITDA
-47
-52
-58
-62
-73
-82
-87
-93
-110
-129
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-45
-50
-57
-60
-66
-74
-76
-80
-96
-115
Income Tax Expense
-1
-2
0
0
0
-
-
-
-
-
Net Income
-44
-50
-57
-60
-66
-74
-76
-80
-96
-115
Net Profit Margin
-1642.85%
-5159.82%
-16606.36%
0.00%
-10457.81%
-18560.15%
0.00%
0.00%
-26807.20%
-11216.00%

Crinetics Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
2
2
1
0
1
4
4
1
Gross Profit
-4
-7
2
1
0
1
4
4
1
Operating Income
-6
-9
-28
-53
-74
-107
-167
-222
-338
EBITDA
-5
-8
-28
-52
-74
-106
-166
-221
-338
Interest Expense
0
0
-
-
0
0
4
-
-
Depreciation
-
0
0
0
0
0
0
1
2
Income Before Tax
-6
-9
-27
-50
-73
-107
-163
-214
-298
Income Tax Expense
0
0
1
0
0
0
-3
0
-
Net Income
-6
-9
-27
-49
-72
-106
-159
-214
-298
Net Profit Margin
-1021.90%
-447.78%
-1116.76%
-4152.14%
-102625.35%
-9899.72%
-3376.69%
-5345.85%
-28720.69%

Crinetics Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-50
-57
-60
-66
-74
-76
-80
-96
-115
Operating Cash Flow
-45
-41
-38
-52
-45
-62
-64
-88
-85
Investing Cash Flow
31
-193
-87
0
-53
20
-542
-85
37
Financing Cash Flow
12
337
37
393
5
57
554
4
7
Change in Cash
-1
103
-87
341
-93
15
-52
-169
-40

Crinetics Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-9
-27
-50
-73
-107
-163
-214
-298
Operating Cash Flow
-9
-19
-46
-62
-88
-115
-166
-225
Investing Cash Flow
0
-119
41
0
-56
-173
-200
-574
Financing Cash Flow
11
170
0
114
252
121
388
1,010
Change in Cash
2
31
-4
52
107
-167
22
209

Global Institutional Holdings in Crinetics Pharmaceuticals Inc

Funds
Holdings
FMR Inc
14.9%
Vanguard Group Inc
9.89%
BlackRock Inc
8.13%
Wellington Management Company LLP
7.32%
Driehaus Capital Management LLC
6.63%

Insights on Crinetics Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 361.0K → 1.03M (in $), with an average increase of 65.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 64.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 112.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 12 quarters, -40.39M → -115.63M (in $), with an average decrease of 10.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CRNX stock has moved down by -3.2%

About Crinetics Pharmaceuticals Inc

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
OrganisationCrinetics Pharmaceuticals Inc
Headquarters6055 Lusk Boulevard, San Diego, CA, United States, 92121
IndustryHealth Technology
CEODr. R. Scott Struthers Ph.D.
E-voting on sharesClick here to vote

Key Management of Crinetics Pharmaceuticals Inc

Name

Title

Dr. Alan S. Krasner M.D.

Chief Endocrinologist

Mr. Kevin Capps

Head of Intellectual Property

Dr. Stephen F. Betz Ph.D.

Co-Founder & Chief Scientific Officer

Dr. Dana Pizzuti M.D.

Chief Medical & Development Officer

Mr. Tobin C. Schilke

Chief Financial Officer

Ms. Garlan Adams J.D.

Chief Legal Officer & Corporate Secretary

Dr. R. Scott Struthers Ph.D.

Founder, President, CEO & Director

Mr. Jeff E. Knight M.P.H.

Chief Operating Officer

Ms. Gayathri Diwakar

Senior Director of Investor Relations

Ms. Adriana Cabre M.B.A.

Chief Human Resources Officer

FAQs

What is Crinetics Pharmaceuticals Inc share price today?

Crinetics Pharmaceuticals Inc share price today is $33.8 as on at the close of the market. Crinetics Pharmaceuticals Inc share today touched a day high of $34.27 and a low of $33.42.

What is the 52 week high and 52 week low for Crinetics Pharmaceuticals Inc share?

Crinetics Pharmaceuticals Inc share touched a 52 week high of $62.53 on and a 52 week low of $24.1 on . Crinetics Pharmaceuticals Inc stock price today i.e. is closed at $33.8,which is 45.95% down from its 52 week high and 40.25% up from its 52 week low.

What is Crinetics Pharmaceuticals Inc's market capitalisation today?

Crinetics Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Crinetics Pharmaceuticals Inc Stock (CRNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Crinetics Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crinetics Pharmaceuticals Inc Shares that will get you 0.0444 shares as per Crinetics Pharmaceuticals Inc share price of $33.8 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Crinetics Pharmaceuticals Inc Stock (CRNX) from India?

Indian investors can start investing in Crinetics Pharmaceuticals Inc (CRNX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Crinetics Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Crinetics Pharmaceuticals Inc share’s latest price of $33.8 as on September 16, 2025 at 1:29 am IST, you will get 0.2959 shares of Crinetics Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Crinetics Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Crinetics Pharmaceuticals Inc stock has given 118.48% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?